A Prospective, Single-center, Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Tazarotene 0.045% Lotion (Arazlo) for Treating Postinflammatory Erythema and Postinflammatory Hyperpigmentation in Subjects With Acne
Latest Information Update: 02 Feb 2023
At a glance
- Drugs Tazarotene (Primary)
- Indications Acne
- Focus Therapeutic Use
Most Recent Events
- 02 Feb 2023 New trial record